路透社3月27日 - 美国司法部周四表示，沃尔格林WBA.O药店将支付超过285万美元，以解决举报人指控该药店向佐治亚州和马萨诸塞州的医疗补助计划多收非专利药品费用的问题。
该和解协议部分解决了根据联邦、佐治亚州和马萨诸塞州《虚假索赔法》对沃尔格林博姿联盟提出的索赔。
沃尔格林药店被指控在2008年至2023年期间向马萨诸塞州医疗保险计划（MassHealth）和佐治亚州医疗补助计划（Georgia Medicaid）提交了一些非专利药的 "通常和惯常 "价格，导致这些计划支付了比他们本应支付的更多的药费。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.